Nuvectra Corporation (NVTR) Tops Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AAPL
2. AMD
3. PLTR
4. DOX
5. VRTX
6. CHKP
7. CRWD
8. ON
9. INSP
10. CVI

Go back to Nuvectra Corporation (NVTR) Tops Q2 EPS by 7c

Nuvectra™ Reports Second Quarter 2017 Financial Results

August 8, 2017 4:01 PM EDT

PLANO, Texas, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced financial results for the second quarter ended June 30, 2017.

Highlights

Record consolidated revenues of $7.2 million, including total Algovita® sales of $5.5 millionCompleted FDA regulatory submission for full-body MRI-conditional approval for the Algovita SCS systemOn track with the Virtis U.S. and European regulatory approval timelines

Scott Drees, CEO, said, During the second quarter our U.S. commercial organization, which includes approximately 50 active... More